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Abstract
Background: Universal human immunodeficiency virus (HIV) screening remains low in many clinical practices
despite published guidelines recommending screening for all patients between ages 13–65. Electronic clinical
decision support tools have improved screening rates for many chronic diseases. We designed a quality
improvement project to improve the rate of universal HIV screening of adult patients in a Midwest primary care
practice using a clinical decision support tool.
Methods: We conducted this quality improvement project in Rochester, Minnesota from January 1, 2014 to
December 31, 2014. Baseline primary care practice HIV screening data were acquired from January 1, 2014 to April
30, 2014. We surveyed providers and educated them about current CDC recommended screening guidelines. We
then added an HIV screening alert to an existing electronic clinical decision support tool and post-intervention HIV
screening rates were obtained from May 1, 2014 to December 31, 2014. The primary quality outcome being
assessed was change in universal HIV screening rates.
Results: Twelve thousand five hundred ninety-six unique patients were eligible for HIV screening in 2014; 327 were
screened for HIV. 6,070 and 6,526 patients were seen before and after the intervention, respectively. 1.80 % of
eligible patients and 3.34 % of eligible patients were screened prior to and after the intervention, respectively
(difference of −1.54 % [−2.1 %, −0.99 %], p < 0.0001); OR 1.89 (1.50, 2.38). Prior to the intervention, African Americans
were more likely to have been screened for HIV (OR 3.86 (2.22, 6.71; p < 0.001) than Whites, but this effect
decreased significantly after the intervention (OR 1.90 (1.12, 3.21; p = 0.03).
Conclusions: These data showed that an electronic alert almost doubled the rates of universal HIV screening by
primary care providers in a Midwestern practice and reduced racial disparities, but there is still substantial room for
improvement in universal screening practices. Opportunities for universal HIV screening remain abundant, as many
providers either do not understand the importance of screening average risk patients or do not remember to
discuss it. Alerts to remind providers of current guidelines and help identify screening opportunities can be helpful.
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Background
Importance of universal HIV screening
The Centers for Disease Control and Prevention (CDC)
estimates that greater than 1.2 million people ≥13 years
in the United States are infected with the human im-
munodeficiency virus (HIV), 14 % of whom are unaware
of their HIV infection [1]. While the incidence of new
HIV infections has remained relatively stable over the
years, almost 50,000 persons were diagnosed with HIV
in 2013 [1]. Previous HIV screening guidelines recom-
mended risk-based screening for HIV in adolescents and
adults. However, this approach fails to detect a large per-
centage of patients eventually diagnosed with HIV [2].
In 2006, the CDC guidelines recommended universal
screening for persons aged 13–64 [3]. In 2013, the
United States Preventive Services Task Force (USPSTF)
released an update to their screening guidelines for pre-
vention of HIV infection, endorsing screening all pa-
tients aged 15–65 years regardless of perceived risk [3].
One of the concerns with adopting routine HIV screen-
ing in our setting has been the popular perception of an
unfavorable cost-benefit profile in areas outside large
urban cities where HIV prevalence is lower, such as our
Midwestern community. However, the CDC has recom-
mended that routine screening be implemented in places
where the prevalence of HIV has been noted to ≥0.1 %,
and even in places where the prevalence of HIV is not
known, the CDC recommends routine screening be im-
plemented unless the prevalence is subsequently deter-
mined to be <0.1 % [4].
History and barriers of HIV screening efforts
Barriers to universal HIV screening can be patient-
related or provider-related. Despite the advances in HIV
diagnosis and management resulting in decreased mor-
tality from HIV, there may still be a perceived stigma as-
sociated with an HIV diagnosis. The World Health
Organization has underscored the need for efforts
worldwide to reduce stigma and discrimination associ-
ated with HIV testing and diagnosis [5, 6]. A focus group
survey of 47 US inner-city individuals revealed that fear
can be an important patient-driven factor in the avoid-
ance of HIV screening – this may include fear of dying,
retaliation against their partners (who are perceived to
have infected them), fear of rejection and discrimination
and concerns of lack of anonymity [7]. Additionally,
there were many misconceptions regarding the epidemi-
ology and transmission of HIV, including fear of becoming
infected with HIV while being tested, and poor under-
standing of the sensitivity of the HIV screening test [7].
Barriers to universal HIV screening is a global issue and
these fears are not limited to the United States. A South
African study found similar perceptions of stigma associ-
ated with HIV, including that HIV-infected individuals
deserved their diagnosis as punishment for their offenses,
and that people would not befriend them if they were diag-
nosed with HIV. [8] Cost of testing and inconvenience of
testing centers and return visits for counselling may also
play roles as patient-driven barriers to HIV screening [7].
Patients may feel invincible and that their self-perceived
risk of HIV acquisition is low, therefore do not feel the need
to be tested. This has been described by African American
men [9] and seems to be on the rise in older adults over
age 50 [10]. Finally, patients can avoid testing because they
would rather not know their diagnosis than have to disclose
it to their partners or families [7], However, patients were
more likely to consider HIV screening if the tests were
rapid, non-invasive, anonymous and inexpensive [7].
Although the CDC issued recommendations in 2006, a
separate World Health Organization document published
in 2007 endorsed “Provider-Initiated HIV Testing and
Counseling” in healthcare facilities only for patients whose
presenting symptoms may be consistent with underlying
HIV infection (in low-level epidemic situations) [11]. It is
not surprising therefore, that it may be difficult for pro-
viders to transition from symptom or risk-based screening
to universal screening, especially in low-prevalence areas,
and there has not been a significant increase in universal
HIV screening practices in the United States after those
recommendations [12]. Most provider HIV screening
practices may differ from their beliefs if they perceive their
community to have a higher or lower prevalence of HIV
than actually exists [13, 14]. Unfamiliarity with current
HIV screening recommendations may be a barrier to ad-
equate screening [15]. Additional barriers to screening
may include uncertainty about consent recommendations,
concern about patient perception, or patient refusal [16].
An important tool for improving universal HIV
screening worldwide is community-based HIV testing
and counseling [17]. This includes door-to-door testing
and mobile testing units for high-risk groups. These
approaches have had higher success rates of earlier HIV
diagnosis and linkage to care than provider-based screen-
ing; however, the rates of new HIV infections identified
with the community-based approach were lower [17]. This
community-based approach was successful in many
middle-low income countries, but fewer studies have been
performed in North America using this approach. Never-
theless, many cost-benefit analyses of universal HIV
screening have identified appreciable cost-diagnosis bene-
fits compared to targeted screening, even in adults over
age 50 and in lower-risk regions where the prevalence of
HIV is >0.1 % [18–23]. Nevertheless, the role of provider-
initiated screening of asymptomatic patients for HIV in
the primary care setting as part of routine preventive ser-
vices remains underappreciated.
Emergency departments represent a healthcare “safety
net”, and as such are pivotal in the frontlines of HIV
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screening, diagnosis and linkage to care. In a Midwestern
emergency department, more patients were tested with uni-
versal screening; this approach identified more new diagno-
ses, however an opt-in consent approach was used rather
than opt-out as recommended by the CDC [24]. Other
hospitals and emergency departments have successfully in-
tegrated opt-out universal HIV screening into their work-
flows [25–27]. One Irish hospital emergency department
utilized an opt-out triple bloodborne pathogen screen for
HIV, hepatitis B and hepatitis C, finding a much higher
prevalence of HIV positive individuals using this method
than previous estimates of prevalence in the community
[28]. In California, a randomized clinical trial comparing
the language used in offering HIV screening reported that
opt-out language significantly increased the uptake of HIV
screening in the emergency department [29].
Population-based informatics in preventive services
Over the last two decades, the revolution of information
technology has transformed healthcare and is now the epi-
center of the movement towards an information-driven,
patient-centered system [30, 31]. Clinical decision support
(CDS) tools successfully enhance chronic disease manage-
ment, medication management and diagnosis [32]. CDS
tools support increased patient involvement in medical
decision-making and improved provider-patient relation-
ship [33]. CDS tools have been used to inform healthcare
providers of drug-drug interactions and use pharmacogen-
etics to identify patients at high risk for adverse reactions
[34, 35]. Additionally, population-based informatics systems
have been implemented to improve preventive services, in-
cluding mammography and osteoporosis [36, 37]. Recently,
similar informatics strategies have been employed for HIV
screening in cities with high HIV prevalence such as New
York City and New Orleans, documenting significant im-
provements with electronic health record (EHR) interven-
tions [38]. Innovative strategies for implementation of
universal HIV screening are needed to augment provider-
initiated and community-based screening efforts.
We designed a quality improvement project to address
the need to improve universal HIV screening rates. We
hypothesized that the addition of an HIV screening
prompt to a CDS would result in improved HIV screen-
ing rates within a perceived “low-risk” Midwestern pri-
mary care internal medicine practice. We also examined
barriers to HIV screening that make the informatics ap-
proach to HIV screening different from the use of in-
formatics in other screening programs.
Methods
Setting/context
Our quality improvement study took place in the Division
of Primary Care Internal Medicine (PCIM), Mayo Clinic
in Rochester, Minnesota, located in Olmsted County. The
population was 37,453 empanelled patients residing in
Rochester and the surrounding rural community. Patients
aged 18 to 34, 35 to 49, and 50 to 64 accounted for 20 %,
21 %, and 28 % respectively of the population. Females
accounted for 56 % of the patients and 29 % were Mayo
Clinic employees. The healthcare providers were 43 inter-
nists, 9 nurse practitioners/physician assistants, and 96 in-
ternal medicine residents. In 2014, there were 142 people
living with HIV in Olmsted County (excluding federal
prisoners) [39].
Root cause analysis
We surveyed 148 PCIM providers prior to the intervention
as a means of obtaining a stakeholder analysis and systems
audit of the problem of inadequate HIV screening. The
REDCap (Research Electronic Data Capture) application
was used to create a secure web-based survey which was
distributed to PCIM providers via email [40]. The survey
assessed providers’ knowledge of current guidelines, behav-
iors and attitudes towards universal HIV screening, and
perceived barriers to successful implementation of universal
HIV screening (Additional file 1: eAppendix 1 & 2). Root
cause analysis is shown in Fig. 1. Providers received another
secure web-based REDCap survey after the intervention to
assess the impact of the intervention. Providers who were
third year Internal Medicine Residents at the time of the
pre-intervention survey and had since graduated were not
available to respond to the post-intervention survey. Simi-
larly, providers who were first year Internal Medicine Resi-
dents at the time of the post-intervention survey could not
have responded to the pre-intervention survey, as they were
not residents in our clinic at that time.
Clinical decision support development
HIV screening alert notifications for the providers were de-
veloped for this study from the Generic Disease Manage-
ment System (GDMS), a web-based knowledge delivery
solution integrated with the Mayo Clinic’s EHR [41].
GDMS uses clinical data in the EHR to determine what
preventive services or chronic disease management tasks
are needed, calculates when they are due, and alerts the
provider. Logic-based rules, based on published clinical
guidelines and validated for other clinical conditions, are
used to determine the recommended actions for each pa-
tient [42]. GDMS delivers these rule-based alerts via a pro-
prietary viewer interface called Synthesis, shown in Fig. 2.
Using the viewer, the alerts fit into the workflow of the pa-
tient visit, which is a crucial part of a successful CDS sys-
tem [43]. Providers also receive a printout of the GDMS
output to enable provider-patient engagement and discus-
sion of the recommendations during the appointment.
GDMS provides both alerts and recommended actions;
alerts are viewable to providers on screen only, while rec-
ommended actions are viewable on screen and on the
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Fig. 1 Fishbone diagram depicting root cause analysis of the problem of inadequate HIV screening among PCIM providers
Fig. 2 Generic Disease Management System (GDMS) interface: “HIV Screening Due” appears under the Alerts for eligible patients
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printout. For the initial intervention pilot, the HIV screen-
ing recommendation was programmed as an alert only (i.e.
viewable only electronically through GDMS in the EHR).
Logic was used to prompt universal HIV screening for
patients between the ages of 18 and 65 who have never
been screened for or diagnosed with HIV. Although
guidelines recommend screening patients between ages
13–17, these patients were not in the adult study popu-
lation and were not included. A patient was considered
to have been previously screened for HIV if the patient
had any of the screening tests shown in Additional file 1:
eTable 1. GDMS also searched the patient’s problem list
for HIV diagnosis codes listed in Additional file 1: eTable
2 as exclusion criteria. If these criteria were met after
real-time assessment by the web services, the HIV rule
was applied and GDMS alerted the provider “HIV
Screening Due” (Fig. 2). Of note, if the alert was deliv-
ered and the patient indicated to the provider during
their visit that they have received an HIV screen else-
where; the provider can note this using a disposition
function stored in the EHR so that an alert is not gener-
ated in subsequent visits.
Clinical decision support implementation
Medical records of patients seen in the PCIM practice from
January 1, 2014 to April 30, 2014 were queried to identify
the baseline HIV screening rate. We met with the providers
to share the data on current screening practices and pro-
vide education about current screening recommendations.
Finally, we showed providers the details of the intervention,
demonstrating exactly what the GDMS screen would look
like with the intervention in place (Fig. 2). These meetings
were followed by several educational and reminder emails
with similar information. After a run in period where rules
were tested and corrected, final implementation was
audited with a sample of 10 patients and showed 100 % ac-
curacy of HIV screening recommendations.
Outcome measures
The numbers of HIV screening tests performed by utiliz-
ing the HIV screening codes described in Additional file
1:eTable 1 and excluding those with diagnosis codes de-
scribed in Additional file 1: eTable 2.
Data collection
Pre-intervention and post-intervention screening data
were obtained from 1/1/14-4/30/14 and 5/1/14-12/31/
14, respectively. Patients with a previous diagnosis of
HIV or HIV-related disorder were excluded.
Statistical analysis
JMP software version 10.0 (Windows ©2005 SAS Insti-
tute, Inc) was used for analysis of the HIV screening data
and the provider survey results. We analyzed patient
characteristics before and after the intervention using
the chi-square test for categorical variables and the t-test
for continuous variables. Logistic regression was used
for modeling with odds ratios and 95 % confidence inter-
vals (CI) reported; the likelihood ratio test statistic was
used for testing of significance.
Results
Six thousand seventy and six thousand five hundred
twenty-six patients were seen prior to and after the
GDMS alert intervention respectively. The cohort con-
sisted of a predominantly white and middle-aged popu-
lation (Table 1). 327 patients were screened for HIV in
2014. 109 (1.80 %) eligible patients were screened prior
to the GDMS alert intervention; 218 (3.34 %) eligible
patients were screened after the intervention (difference
of −1.54 % [−2.1 %, −0.99 %], p < 0.001). As a cohort,
there were no age or sex differences in screening before
and after the intervention, with a mean age of 48 years
in both groups (Table 1). Prior to the intervention, Afri-
can Americans were more likely to have been screened
for HIV (OR 3.86 (2.22, 6.71; p < 0.001) than Whites,
but this effect decreased significantly after the interven-
tion (OR 1.90 (1.12, 3.21; p = 0.03) (Table 2). No new
HIV diagnoses or false positives were identified.
Survey results
Of the 148 Internal Medicine providers surveyed before
the intervention, 68 providers (45.9 %) responded. 63 %
of responding providers did not universally screen all eli-
gible patients for HIV, most commonly citing that they
did not remember to discuss screening (52 %). 33 %
were not familiar with current screening guidelines,
and 25 % of providers did not believe in screening pa-
tients they perceived to be “low-risk”. 4 % of providers
indicated that they were uncomfortable with the discus-
sion. Figure 3 describes the survey responses regarding
screening practices, by provider training level. Across
all training levels, before the intervention, the over-
whelming practice was to screen only perceived “high
risk” patients for HIV. However, prior to the interven-
tion, 88 % of the responding providers indicated that
they would screen more patients for HIV if the GDMS
system had an HIV screening prompt.






Patients screened, (%) 109 (1.80) 218 (3.34) <0.001
Mean age [SD], yrs. 48.9 [12.3] 48.4 [12.6] 0.01
Female sex (%) 3464 (57.1) 3535 (54.2) 0.001
White race, (%) 5105 (84.1) 5533 (84.8) 0.21
SD standard deviation
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After the intervention, the providers were re-surveyed
and 36 (24.3 %) responded. 78 % of responding providers
were aware of the GDMS electronic prompt. Ten pro-
viders (27 %) indicated that they still only screened high-
risk patients for HIV; 75 % indicated that they would be
more likely to screen if the recommendation was view-
able to patients also. 64 % of responding providers felt
that the intervention helped to educate them about HIV
screening, and 42 % felt that more of their patients
agreed to the test after the intervention was imple-
mented. Figure 4 describes the survey responses regard-
ing screening practices, by provider training level.
Across all training levels, after the intervention, more
providers endorsed that they tried to screen most eli-
gible patients for HIV.
Discussion
This CDS intervention improved the HIV screening
practices of primary care providers. However, the small
absolute numbers may reflect the continued perception
that our community population is at low risk for HIV in-
fection. In an Ohio community Internal Medicine train-
ing program, HIV screening rates were successfully
increased from 0.4 % to 16.9 % [44]. In that program, a
trained medical assistant suggested HIV screening at the
beginning of the visit. However, this study differs from
Table 2 Odds Ratios and 95 % Confidence Intervals for HIV screening within demographic groups before and after GDMS intervention
Demographic variable: Pre-intervention p valuea Post-intervention p valuea
Odds Ratio (95 % CI) Odds Ratio (95 % CI)
Age 18–24 0.34 (0.11, 1.11) 0.037b 1.29 (0.75, 2.20) 0.37 b
25–39 1 – 1 –
40–49 0.35 (0.20, 0.63) <0.001b 0.50 (0.33, 0.78) 0.001b
50+ 0.27 (0.18, 0.42) <0.001b 0.57 (0.42, 0.79) <0.001b
Sex Female 1 – 1 –
Male 1.26 (0.86, 1.85) 0.23 1.21 (0.92, 1.59) 0.1639
Race White 1 – 1 –
Asian 0.88 (0.32, 2.42) 0.80c 1.71 (1.02, 2.85) 0.06c
AA 3.86 (2.22, 6.71) <0.001c 1.90 (1.12, 3.21) 0.03c
Otherd 2.48 (1.27, 4.86) 0.02c 1.41 (0.76, 2.63) 0.30c
Unknown 3.44 (1.23, 9.64) 0.05c 2.25 (1.03, 4.91) 0.07c
AA African American, CI confidence interval
aLikelihood ratio test
bCompared to subjects aged 25–39
cCompared to white race
dIncludes Native Hawaiians, Pacific Islanders, Native Americans
Fig. 3 Chart showing pre-intervention survey response regarding provider HIV screening practice, by training level
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ours in that (1) their clinic serves a largely uninsured,
medically indigent or low income population, (2) the
clinic served fewer patients than our clinic and (3) they
offered HIV testing to all patients entering the clinic re-
gardless of prior HIV screening status [44].
African Americans continue to be disproportionately
affected by the HIV epidemic, with 44 % of new HIV in-
fections occurring in this group [1]. Perhaps for this rea-
son, African Americans in this cohort were screened
more often than other racial/ethnic groups (Table 2). Of
interest, while the proportion of African Americans
screened before and after the intervention remained
constant, the proportion of White patients screened
after the intervention significantly increased from 1.47 %
to 3.02 %, OR 2.09 (1.59, 2.75), p < 0.001 (Table 3). Add-
itionally, the age groups that seemed to benefit the most
from the intervention were the youngest (18–24) and
oldest (50+) cohorts – both of these groups showed sig-
nificant improvement in overall screening rates after the
intervention. Provider initiated screening in these age
groups is especially important. Youth in the 18–24 year
old age group tend to feel invincible and do not perceive
themselves at risk for HIV, and older adults over age 50
tend to consider other disorders of aging to explain
symptoms before thinking of risk for HIV [1]. Our re-
sults indicate that an electronic reminder can facilitate a
more truly universal screening program, with all gender,
race/ethnic groups and age groups being screened ac-
cording to eligibility.
Despite updates to HIV screening recommendations,
universal screening rates remain unsatisfactory. In a
2009 study of Internal Medicine providers, 88 % re-
ported knowledge of universal screening recommenda-
tions, yet only 50 % endorsed any increase in their
screening rates [13]. Perceived conflict with other patient
priorities, anticipated patient refusal, or concerns about
reimbursement often serve as barriers to optimal screen-
ing [13]. Therefore, risk-based screening remains popu-
lar despite widespread knowledge about the benefits of
universal screening [12].
It is easy to envision that screening practices can be im-
proved with education and electronic screening tools in
larger urbanized areas such as the New York Metropolitan
area or New Orleans [38]. In these cities, the “at risk”
population is considered because of behavioral differences
and larger population size. In smaller cities, universal
screening strategies may be more difficult to implement
since providers’ perceptions of screening need are less ob-
vious. Some of our providers believed that the community
served by our institution is over-served and our focus
should be on patients living in rural areas. Despite geo-
graphic differences in access to care, the premise of uni-
versal HIV screening is that risky behaviors leading to
acquisition of HIV are present across all social, ethnic,
economical and age strata.
The CDS itself may pose certain barriers. Healthcare
providers may not be aware that it exists or know how
to use the information within the CDS [45]. Addition-
ally, they may encounter conflict when utilizing the CDS
to achieve certain patient-care goals when these goals
are not shared by the patients [45]. Most patients do not
come to the doctor’s office thinking about HIV screen-
ing. Furthermore, there are many barriers to HIV screen-
ing. First, many healthcare providers may not be aware
of the 2006 CDC recommendations for universal HIV
screening. In the past, providers needed separate written
consent and pretest and posttest counseling to screen
for HIV, and some providers do not realize these actions
Fig. 4 Chart showing post-intervention survey response regarding provider HIV screening practice, by training level
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are no longer required in most states, with few excep-
tions [4]. Because of such education gaps, a study like
this often requires a multi-centered approach with both
electronic reminders and provider education. While such
an approach may lead to overall improvement in screen-
ing, it makes it difficult to determine if the effect is due
to the alert or the education, or both; this is a common
issue with positive CDS studies [46].
Providers also feel insecure about discussing HIV
testing with patients, as this may strain the patient-
provider relationship. Providers may try to avoid mak-
ing the patient feel that they are passing judgement on
their sexual risk factors, and in doing so may com-
pletely avoid discussions about sexually transmitted dis-
ease screening in the absence of patient prompting.
This alludes to a persistent perceived stigma associated
with HIV screening and diagnosis. Many patients doubt
the confidentiality of HIV testing, and may deny being
at risk for HIV [16]. Because patients need increased
reassurance regarding confidentiality, it is perceived
that delivery of HIV test results requires an extra layer
of security. If patients can be reasonably reassured that
HIV screening is as routine as their cancer or choles-
terol screening, and that all patient encounters and test
results are confidential regardless of type of discussion
or test, the provider-patient relationship could likely be
maintained without conflict.
Future enhancements
Information technology regarding HIV screening re-
quires enhancements in other areas. Since 1985, donated
blood has been tested for HIV, therefore patients who
have had donated blood accepted in the past must be
HIV-negative. However, if the blood donor database is
not synchronized with the patient’s medical record, then
it would appear that the patient was never screened for
HIV. A useful enhancement would be to create a back-
ground link between the medical record and blood
donor database so that providers considering recom-
mending universal HIV screening would be alerted if the
patient had recently successfully donated blood. This
would also provide a counterbalance measure to avoid
over-testing in patients whose donated blood recently
passed infectious diseases screening tests. The percent
increase in HIV screening rate in the PCIM clinic was
modest at best, and absolute numbers were still disap-
pointing. While this particular quality improvement
project did not identify any newly diagnosed HIV pa-
tients, the opportunity still exists to further increase
both provider confidence in the necessity of universal
screening and improve the ease of recommending this
screening to their patients.
Notifying patients through patient online services, or
phone calls makes universal HIV screening more conveni-
ent because the patients may be screened concurrently
with other recommended labs prior to visiting their pro-
vider. Utilization of online reminders may not be desirable
however, as they preclude patients from being able to ask
questions regarding the recommendations, and telephone
recommendations would impose a time–cost burden on
nurses or desk staff. Provider audits and addition of HIV
screening to institution performance metrics may also
complement the electronic prompt system [43]. Self-
auditing has been shown to improve HIV screening rates
in a Midwest internal medicine residency practice [47].
There is a call to action to further enhance the contribu-
tion of health information technology to improve the clin-
ical decision-making capacity of providers [48]. Though
Table 3 Comparison of overall HIV screening rates and by demographic group before and after GDMS intervention
Demographic Category Pre intervention HIV screening (%)
n = 6070 eligible
Post Intervention HIV screening (%);
n = 6526 eligible
Odds Ratio (95 % CI) p valuea
All eligible 1.80 3.34 1.89 (1.50, 2.38) <0.001
Sex Female 1.62 3.06 1.92 (1.38, 2.66) <0.001
Sex Male 2.03 3.68 1.84 (1.32, 2.56) <0.001
Age 18–24 1.42 6.14 4.54 (1.32, 15.6) 0.005
Age 25–39 4.03 4.85 1.21 (0.83, 1.76) 0.31
Age 40–49 1.47 2.51 1.73 (0.94, 3.18) 0.07
Age 50+ 1.13 2.83 2.54 (1.76, 3.68) <0.001
Race: White 1.47 3.02 2.09 (1.59, 2.75) <0.001
Race: AA 5.44 5.57 1.03 (0.51, 2.09) 0.94
Race: Asian 1.29 5.04 4.05 (1.35, 12.2) 0.005
Race: Otherb 3.57 4.20 1.18 (0.49, 2.83) 0.71
Race: Unknown 4.88 6.54 1.37 (0.39, 4.83) 0.63
AA African American, CI confidence interval
aLikelihood ratio test
bIncludes Native Hawaiians, Pacific Islanders, Native Americans
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their direct impact on patient health outcomes (e.g. mor-
tality) still needs to be studied, automated CDS systems
increase provider performance with respect to prevention,
diagnosis, and chronic disease management, and should
not be overlooked when considering areas for practice im-
provement [32].
Limitations
The GDMS HIV screening prompt was available only elec-
tronically to the providers as an “alert” through the EHR,
but was not available on the patient printout. The printout
serves as a starting point for discussions between patients
and providers about recommended preventive services.
Most providers indicated their willingness to screen more
often if the prompt was a “recommended action” so that
patients could recognize that this is a part of the normal
preventive service recommendations and not an assump-
tion about their sexual habits. This planned upgrade
should boost HIV screening in our practice as a routine
part of the shared decision-making process at clinical
visits. With this further intervention, we hope to eliminate
provider insecurity with HIV screening discussions and
patient insecurity with perceived judgement or stigma as-
sociated with screening.
While it would have been ideal to determine the true
number of opportunities to intervene and screen for
HIV, including non-face-to-face encounters, this was not
feasible, therefore the surrogate for this was the number
of appointments. There were multiple unique appoint-
ments per patient, and it was difficult to determine
exactly which appointment resulted in the screening op-
portunity, as patients do not always perform tests imme-
diately after an appointment, and sometimes HIV
screening could have been batched with “next visit” fu-
ture testing. For the same reason, it was not feasible to
obtain reliable data on number of HIV tests ordered vs.
those completed, as tests often have to be re-ordered
when patients miss lab appointments. Similarly, it was
not feasible to identify which patients opted-out of HIV
screening despite provider recommendation, as this was
not mentioned in medical notes. In addition, records
from the Family Medicine and outreach clinic practices
were excluded; this could have introduced a selection
bias as screening practices may be different in other
local primary care practices.
Furthermore, while it would have been interesting to
evaluate screening tests by provider training level, it was
not possible to do so accurately, as our electronic pro-
gram only maps current providers to appointments.
Since a majority of third year medical residents had
graduated by the time the data was collected, their
names could no longer be mapped to the appointments
they had prior to graduation. Finally, applicability of
these quality improvement practices outside our
institution could potentially be limited with the use of
GDMS only at this institution, but the premise of our
study with an electronic prompt and CDS can be applied
to any electronic medical record.
Conclusions
Universal HIV screening can be significantly increased
with the use of electronic CDS alerts at the point of care.
This HIV screening enhancement has been sustainable
and continues to be a part of the CDS system in our in-
stitution. Given the low absolute screening rates, there is
still substantial room for improvement in universal HIV
screening, especially among perceived “low prevalence
areas.” These results can serve as a benchmark to other
institutions and a starting point for further development
of ways to increase HIV screening.
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